Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Feb. 11, 2020	50,325,662
Ending balance (in shares) at Feb. 12, 2020	4,171,571
Beginning balance (in shares) at Mar. 31, 2020		35,135,520
Beginning balance at Mar. 31, 2020	$ (21,169)	$ 4	$ 127,683	$ (148,102)	$ (754)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	3,475	3,475
Stock options exercised	$ 14		14
Restricted stock awards issued (in shares)	139,501
Issuance of common stock (in shares)		5,000,000
Issuance of common stock (Note 9)	$ 13,646		13,646
Stock-based compensation	1,393		1,393
Other comprehensive loss	(18)				(18)
Net loss	(13,722)			(13,722)
Ending balance (in shares) at Dec. 31, 2020		40,278,496
Ending balance at Dec. 31, 2020	(19,856)	$ 4	142,736	(161,824)	(772)
Beginning balance (in shares) at Sep. 30, 2020		35,266,496
Beginning balance at Sep. 30, 2020	$ (29,488)	$ 4	128,385	(157,112)	(765)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	0
Restricted stock awards issued (in shares)		12,000
Issuance of common stock (in shares)		5,000,000
Issuance of common stock (Note 9)	$ 13,646		13,646
Stock-based compensation	705		705
Other comprehensive loss	(7)				(7)
Net loss	(4,712)			(4,712)
Ending balance (in shares) at Dec. 31, 2020		40,278,496
Ending balance at Dec. 31, 2020	$ (19,856)	$ 4	142,736	(161,824)	(772)
Beginning balance (in shares) at Mar. 31, 2021	40,531,996	40,531,996
Beginning balance at Mar. 31, 2021	$ (25,055)	$ 4	144,201	(168,403)	(857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	31,925	31,925
Stock options exercised	$ 134		134
Vesting of restricted stock units (in shares)		12,750
Issuance of common stock (in shares)		9,370,251
Issuance of common stock (Note 9)	50,273	$ 1	50,272
Conversion of promissory note (Note9) (in shares)		3,120,000
Conversion of promissory note (Note 9)	14,378		14,378
Stock-based compensation	1,856		1,856
Other comprehensive loss	(131)				(131)
Net loss	$ (5,236)			(5,236)
Ending balance (in shares) at Dec. 31, 2021	53,066,922	53,066,922
Ending balance at Dec. 31, 2021	$ 36,219	$ 5	210,841	(173,639)	(988)
Beginning balance (in shares) at Sep. 30, 2021		41,664,020
Beginning balance at Sep. 30, 2021	$ (19,546)	$ 4	150,843	(169,475)	(918)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)	0
Vesting of restricted stock units (in shares)		9,750
Issuance of common stock (in shares)		8,273,152
Issuance of common stock (Note 9)	$ 44,773	$ 1	44,772
Conversion of promissory note (Note9) (in shares)		3,120,000
Conversion of promissory note (Note 9)	14,378		14,378
Stock-based compensation	848		848
Other comprehensive loss	(70)				(70)
Net loss	$ (4,164)			(4,164)
Ending balance (in shares) at Dec. 31, 2021	53,066,922	53,066,922
Ending balance at Dec. 31, 2021	$ 36,219	$ 5	$ 210,841	$ (173,639)	$ (988)